Volume dodolan perusahaan Prothena Corporation plc (PRTA)
High risks of clinical trial failure and regulatory pressure create financial threats for Prothena Corporation (PRTA). The company's total sales confirm this volatility, and this metric equals 0.05. This trend is driven by the development of innovative methods to combat Parkinson's and Alzheimer's diseases, while laboratory stability is maintained through the diversification of pure raw material supply chains.
Rincian analitis perusahaan Prothena Corporation
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Prothena Corporation|PRTA - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Prothena Corporation PLC|PRTA - Utang perusahaan|Rasio utang marang aset resik Prothena Corporation plc|PRTA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Prothena|Likuiditas darurat prothena.com
- data bathi resik lan rasio valuasi:
PRTA - Bathi resik perusahaan|Penghasilan resik sing dikarepake Prothena Corporation|PRTA - Pangali P/E|Pangali Forward P/E Prothena Corporation|PRTA - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Prothena Corporation plc|PRTA - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Prothena|PRTA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan prothena.com|PRTA - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Prothena Corporation
- rincian pendapatan lan dodolan emiten:
Analisis komprehensif perusahaan:Prothena Biosciences - PRTA
The sales volume dynamics of Prothena Corporation (PRTA) reflect the effectiveness of drug commercialization amid geopolitical barriers in clinical trials. This indicator captures daily operating income, serving as an objective measure of cash flow. The calculation is based on the total funds received per day, revealing the gap between the market share price and actual cash. It is critical for investors to compare this flow with R&D expenditures. The stability of the curve confirms the business model's resilience to logistical sanctions.
Analisis perusahaan pesaing
Total pendapatan perusahaan Biogen Idec BIIB|Pendapatan perusahaan Neurocrine Biosciences (NBIX)|regencellbioscience.com - Volume dodolan perusahaan|Pendapatan lan volume dodolan AXSM (Axsome Therapeutics, Inc.)|Pendapatan lan volume dodolan ACADIA Pharma ACAD|XENE: Dodolan perusahaan|Pendapatan dodolan perusahaan VKTX (Viking Therapeutics Corp)|SUPN: Pendapatan lan volume dodolan|Dodolan perusahaan catalystpharma.com|Pendapatan perusahaan Denali Therapeutics Inc.|Total pendapatan perusahaan Harmony Biosciences Inc HRMY|Pendapatan perusahaan Biohaven Pharmaceutical (BHVN)|AMLX (Amylyx Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Trevi Therapeutics TRVI|PRAX (praxismedicines.com) - Pendapatan tahunan perusahaan|AVXL - Pendapatan perusahaan|Total pendapatan perusahaan CeriBell Inc|alector.com (ALEC) - Pendapatan perusahaan|Annexon Biosciences Inc. - Pendapatan dodolan perusahaan|OMER (Omeros Corp) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan neurogene.com|Dodolan perusahaan ACIU (AC Immune SA)|Total dodolan perusahaan VYGR|Pendapatan lan volume dodolan NMRA (Neumora Therapeutics Inc)|Pendapatan reged perusahaan Scilex Holding Company, Inc. (SCLX)|TVGN - Pendapatan perusahaan|Total pendapatan perusahaan Alpha Cognition|Cognition Therapeutics (CGTX) - Pendapatan perusahaan|Volume dodolan perusahaan IKT|Pendapatan perusahaan Cassava|Assertio Therapeutics - Pendapatan tahunan perusahaan|Pendapatan perusahaan Coya Therapeutics, Inc. (COYA)|VTGN (vistagen.com) - Pendapatan dodolan perusahaan|Ovid Therapeutics - Dodolan perusahaan|Total dodolan perusahaan ABOS (Acumen Pharmaceuticals Inc.)|CervoMed Inc - Pendapatan lan volume dodolan|ATHE - Pendapatan lan volume dodolan|clene.com (CLNN) - Pendapatan perusahaan|Volume dodolan perusahaan PEPG|JUNS (Jupiter Neurosciences Inc) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Relmada Therapeutics Inc RLMD|Dodolan perusahaan ANVS (Annovis Bio Corp)|Pendapatan lan volume dodolan gracetx.com (GRCE)|Pendapatan perusahaan Firefly Neuroscience, Inc AIFF|Pendapatan dodolan perusahaan KLTO|NRSN - Pendapatan perusahaan|Total pendapatan perusahaan Reviva Pharmaceuticals Holdings Inc.|metaviatx.com (MTVA) - Pendapatan perusahaan|Pendapatan tahunan perusahaan NRXS (NeurAxis Inc)|Pendapatan perusahaan Helius Medical Technologies, Inc.|PASG: Pendapatan dodolan perusahaan|Pendapatan perusahaan Neuphoria Therapeutics Inc. (NEUP)|NERV - Total pendapatan perusahaan|Athira - Dodolan perusahaan|Total dodolan perusahaan ADXN (Addex)|Alzamend - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan CYCN (Cyclerion Therapeutics)|PTIX: Pendapatan lan volume dodolan|Total pendapatan perusahaan Pasithea Therapeutics Corp. (KTTA)|Pendapatan perusahaan Cortigent Inc|Volume dodolan perusahaan ATXI (Avenue Therapeutics Inc)|Pendapatan lan volume dodolan BCLI|Pendapatan lan volume dodolan caratherapeutics.com (CARA)|Chromocell Therapeutics Corp. - Dodolan perusahaan|Pendapatan dodolan perusahaan ELYM|Intra-Cellular - Pendapatan lan volume dodolan|Longboard (LBPH) - Dodolan perusahaan|Marinus Pharmaceuticals (MRNS) - Pendapatan perusahaan|Total pendapatan perusahaan nkgenbiotech.com (NKGN)|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|SAGE: Pendapatan dodolan perusahaan|Pendapatan perusahaan Neurotrope (SNPX)|TRVN: Pendapatan tahunan perusahaan|Pendapatan perusahaan Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Total pendapatan perusahaan|CERE - Pendapatan perusahaan
